DOI: https://dx.doi.org/10.18203/2349-3291.ijcp20220093
Published: 2022-01-24

Benign cyst or malignancy? A six-year-old with primitive small round cell sarcoma of the right buttock: a case report

Michelle L. Amit, Lori Barr, Erlyn Smith

Abstract


A six-year-old male presents with mass on his right buttock. After surgical resection, he was found to have a primitive small round cell sarcoma, high grade with CIC-DUX4 fusion gene. Treatment started with compressed regimen of VDC/IE (compressed Ewing protocol). There was initial improvement in visual appearance of the buttock/wound site but recurrence of the tumor occurred despite extensive surgical resection along with metastases to the lungs and bone which progressed and eventually led to death. This case adds to the collective knowledge regarding the CIC-DUX4 type of pediatric neoplasms and provides insight for future chemotherapy protocols.


Keywords


Primitive small round cell sarcoma, Pediatric sarcoma, Gluteal mass, Pelvis mass, CIC-DUX4, Metastasis

Full Text:

PDF

References


Borden EC, Baker LH, Bell RS, Bramwell V, Demetri GD, Eisenberg BL, et al. Soft tissue sarcomas of adults: state of the translational science. Clin Cancer Res. 2003;9(6):1941-56.

Pappo AS, Devidas M, Jenkins J, Rao B, Marcus R, Thomas P, et al. Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study. J Clin Oncol. 2005;23(18):4031-8.

Pappo AS, Pratt CB. Soft tissue sarcomas in children. Cancer Treat Res. 1997;91:205-22.

Nakai S, Yamada S, Outani H, Nakai T, Yasuda N, Mae H, et al. Establishment of a novel human CIC-DUX4 sarcoma cell line, Kitra-SRS, with autocrine IGF-1R activation and metastatic potential to the lungs. Sci Rep. 2019;9(1):15812.

Siegele B, Roberts J, Black JO, Rudzinski E, Vargas SO, Galambos C. DUX4 Immunohistochemistry Is a Highly Sensitive and Specific Marker for CIC-DUX4 Fusion-positive Round Cell Tumor. Am J Surg Pathol. 2017;41(3):423-9.

Okimoto RA, Wu W, Nanjo S, Olivas V, Lin YK, Ponce RK, Oyama R, Kondo T, Bivona TG. CIC-DUX4 oncoprotein drives sarcoma metastasis and tumorigenesis via distinct regulatory programs. J Clin Invest. 2019;129(8):3401-6.

Deniz K, Huryn JM, Kao YC, Huang SC, Singer S, Tap W, Schaefer IM, Fletcher CD. Sarcomas With CIC-rearrangements Are a Distinct Pathologic Entity With Aggressive Outcome: A Clinicopathologic and Molecular Study of 115 Cases. Am J Surg Pathol. 2017;41(7):941-9.

Bleyer WA, Tejeda H, Murphy SB, Robison LL, Ross JA, Pollock BH, et al. National cancer clinical trials: children have equal access; adolescents do not. J Adolesc Health. 1997;21(6):366-73.

Bleyer A, Montello M, Budd T, Saxman S. National survival trends of young adults with sarcoma: lack of progress is associated with lack of clinical trial participation. Cancer. 2005;103(9):1891-7.

Graham C, Chilton-MacNeill S, Zielenska M, Somers GR. The CIC-DUX4 fusion transcript is presenting a subgroup of pediatric primitive round cell sarcomas. Human Pathology. 2012; 43:180-9.

Pratt CB, Maurer HM, Gieser P, Salzberg A, Rao BN, Parham D, et al. Treatment of unresectable or metastatic pediatric soft tissue sarcomas with surgery, irradiation, and chemotherapy: a Pediatric Oncology Group study. Med Pediatr Oncol. 1998;30(4):201-9.

Pratt CB, Pappo AS, Gieser P, Jenkins JJ, Salzbergdagger A, Neff J, Rao B, Green D, Thomas P, Marcus R, Parham D, Maurer H. Role of adjuvant chemotherapy in the treatment of surgically resected pediatric nonrhabdomyosarcomatous soft tissue sarcomas: A Pediatric Oncology Group Study. J Clin Oncol. 1999;17(4):1219.

Ricker CA, Berlow NE, Crawford KA, Georgopapadakos T, Huelskamp A, Woods AD, et al. Undifferentiated small round cell sarcoma in a young male: a case report. Cold Spring Harb Mol Case Stud. 2020;6:a004812.

Ries LA, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. Bethesda, National Cancer Institute, SEER Program. NIH Pub. 1999;99-4649.

Spunt SL, Skapek SX, Coffin CM. Pediatric nonrhabdomyosarcoma soft tissue sarcomas. Oncologist. 2008;13:668-78.

Whelan J, Khan A, Sharma A, Rothermundt C, Dileo P, Michelagnoli M, et al. Interval compressed vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide, etoposide in patients with advanced Ewing's and other Small Round Cell Sarcomas. Clin Sarcoma Res. 2012;2(1):12.

Yoshimoto M, Graham C, Chilton-MacNeill S, Lee E, Shago M, Squire J, Zielenska M, Somers GR. Detailed cytogenetic and array analysis of pediatric primitive sarcomas reveals a recurrent CIC-DUX4 fusion gene event. Cancer Genet Cytogenet. 2009;195(1):1-11.